Serrated lesions of the colorectum: Review and recommendations from an expert panel

American Journal of Gastroenterology

Volumn 107, Issue 9, 2012, Pages 1315-1329

  Rex, Douglas K ^a   Ahnen, Dennis J ^b   Baron, John A ^c   Batts, Kenneth P ^d   Burke, Carol A ^e   Burt, Randall W ^f   Goldblum, John R ^e   Guillem, José G ^g   Kahi, Charles J ^h   Kalady, Matthew F ^e   O'Brien, Michael J ⁱ   Odze, Robert D ^j   Ogino, Shuji ^j,k   Parry, Susan ^l,m   Snover, Dale C ⁿ   Torlakovic, Emina Emilia ^o   Wise, Paul E ^p   Young, Joanne ^q   Church, James ^e  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d ABBOTT NORTHWESTERN HOSPITAL   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k DANA FARBER CANCER INSTITUTE   (United States)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

^m MIDDLEMORE HOSPITAL   (New Zealand)

ⁿ FAIRVIEW SOUTHDALE HOSPITAL   (United States)

^o UNIVERSITY HEALTH NETWORK   (Canada)

^p VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^q CANCER COUNCIL QUEENSLAND   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLONOSCOPY; COLORECTAL CANCER; COLORECTAL DISEASE; COLORECTAL POLYP; HISTOPATHOLOGY; HUMAN; POLYPECTOMY; PRIORITY JOURNAL; RECTUM ADENOMA; REVIEW; WORLD HEALTH ORGANIZATION;

ADENOMA; COLON; COLONIC DISEASES; COLONIC POLYPS; COLORECTAL NEOPLASMS; HUMANS; RECTAL DISEASES; RECTUM;

EID: 84866091151     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.161     Document Type: Review

References (154)

1. Lane N. The precursor tissue of ordinary large bowel cancer. Cancer Res 1976;36 (7 Part 2): 2669-72.
2. Sumner HW, Wasserman NF, McClain CJ. Giant hyperplastic polyposis of the colon. Dig Dis Sci 1981;26:85-9.
3. Cooper HS, Patchefsky AS, Marks G. Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum 1979;22:152-6.
4. Urbanski SJ, Kossakowska AE, Marcon N et al. Mixed hyperplastic adeno-matous polyps-an underdiagnosed entity. Report of a case of adenocarci-noma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol 1984;8:551-6.
5. Franzin G, Zamboni G, Scarpa A et al. Hyperplastic (metaplastic) polyps of the colon: a histologic and histochemical study. Am J Surg Pathol 1984;8:687-98.
6. Jass Jr. Metaplastic polyps and polyposis of the colorectum. Histopathol-ogy 1980;4:579.
7. Jass Jr. Relation between metaplastic polyp and carcinoma of the colorec-tum. Lancet 1983;1:28-30.
8. Fenoglio-Preiser CM. Hyperplastic polyps, adenomatous polyps, and mixed hyperplastic adenomatous polyps of the colon: defnitions. Prog Clin Biol Res 1988; 279: 3-12.
9. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-37.
10. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55.
11. Torlakovic E, Skovlund E, Snover DC et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81.
12. Montgomery E. Serrated colorectal polyps: emerging evidence suggests the need for a reappraisal. Adv Anat Pathol 2004;11:143-9.
13. Snover D, Jass, Fenoglio-Preiser C et al. Serrate dpolyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005;124:380-91.
14. East JE, Saunders BP, Jass Jr. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008;37:25-46.
15. Nofsinger AE, Hart J. Serrated adenoma: a distinct form of non-polypoid colorectal neoplasia? Gastrointest Endosc Clin N Am 2010;20:543-63.
16. Leggett B, Whitehall V. Role of the serrated pathway in colorectal can cer pathogenesis. Gastroenterology 2010;138:2088-100.
17. Huang CS, Farraye FA, Yang S et al. The clinical significance of serrated polyps. Am J Gastroenterol 2011;106:229-40.
18. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011;42:1-10.
19. Snover D, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated ("hyperplastic") polyposis. In: Bozman FT, Carneiro F, Hruban RH, et al, (eds) WHO Classification of Tumours Pathology and genetics Tumours of the digestive system, 4th edn. Berlin: Springer-Verlag, 2010.
20. Guyatt G, Gutterman D, Baumann MH et al. Grading strengthofrecom- mendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest 2006;129:174-81.
21. Torlakovic EE, Gomez JD, Driman DK et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008;32:21-9.
22. Khalid O, Radaideh S, Cummings OW et al. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009;15:3767-70.
23. Glatz K, Pritt B, Glatz D et al. A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am J Clin Pathol 2007;127:938-45.
24. Sandmeier D, Seelentag W, Bouzourene H. Serrated polyps of the colorec-tum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch 2007; 450: 613-8.
25. Sheridan TB, Fenton H, Lewin MR et al. Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas: an immunohisto-chemical study of serrated lesions " caught in the act ". Am J Clin Pathol 2006;126:564-71.
26. Yantiss RK, Oh KY, Chen YT et al. Filiform serrated adenomas: a clinico-pathologic and immunophenotypic study of 18 cases. Am J Surg Pathol 2007;31:1238-45.
27. Kim KM, Lee EJ, Kim YH et al. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 2010;34:667-75.
28. Pai RK, Mackinnon AC, Joseph L et al. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. Am J Surg Pathol 2010;34:355-63.
29. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst 2010;102:365-7.
30. Toyota M, Ahuja N, Ohe-Toyota M et al. Cp G island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-6.
31. Samowitz WS, Albertsen H, Herrick J et al. Evaluation of alarge, population-based sample supports a Cp G island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
32. Hawkins N, Norrie M, Cheong K et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroen-terology 2002;122:1376-87.
33. Ogino S, Nosho K, Kirkner GJ et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-6.
34. Nosho K, Yamamoto H, Takamaru H et al. A caseofcolorectal carcinoma in adenoma analyzed by a cDNA array. Int J Colorectal Dis 2005; 20: 287-91.
35. Nagasaka T, Koi M, Kloor M et al. Mutationsinboth KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 2008;134:1950-60.
36. Rajagopalan H, Bardelli A, Lengauer C et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
37. Kambara T, Simms LA, Whitehall VL et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004;53:1137-44.
38. Weisenberger DJ, Siegmund KD, Campan M et al. CpG islandmethylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38:787-93.
39. Chan TL, Zhao W, Leung SY et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003; 63: 4878-81.
40. Jass JR, Iino H, Ruszkiewicz A et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000;47:43-9.
41. Park SJ, Rashid A, Lee JH et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003;162:815-22.
42. Goldstein NS, Bhanot P, Odish E et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003;119:778-96.
43. Velho S, Moutinho C, Cirnes L et al. BRAF, KRASand PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 2008;8:255.
44. O'Brien MJ, Yang S, Mack C et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30:1491-501.
45. Kakar S, Deng G, Cun L et al. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Hum Pathol 2008; 39: 30-6.
46. Rashid A, Shen L, Morris JS et al. CpG island methylation in colorectal adenomas. Am J Pathol 2001;159:1129-35.
47. Yamauchi M, Morikawa T, Kuchiba A et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal vs distal colorectum. Gut 2012;61: 847-54.
48. Ngo NT, Tan E, Tekkis P et al. Difierential expression of p53 and p504 s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. Int J Colorectal Dis 2010;25:1193-200.
49. Whitehall VL, Walsh MD, Young J et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-30.
50. Ogino S, Kawasaki T, Kirkner GJ et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut 2007;56:1564-71.
51. Clark JC, Collan Y, Eide TJ et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985;36:179-86.
52. Correa P, Strong JP, Reif A et al. Epidemiology of colorectal polyps-prevalence in New Orleans and international comparisons. Cancer 1977;39:2258-64.
53. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 1978;42:2839-48.
54. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 1992;33:1508-14.
55. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol 1989;24: 799-806.
56. Stemmermann GN, Yatani R. Diverticulosis and polyps of the large intestine. A necropsy study of Hawaii Japanese. Cancer 1973;31:1260-70.
57. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-25.
58. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-42.
59. Hassan C, Pickhardt PJ, Marmo R et al. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum 2010;53:1328-33.
60. Lieberman DA, Prindiville S, Weiss DG et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959-67.
61. Omata F, Brown WR, Tokuda Y et al. Modifable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med 2009;48:123-8.
62. Provenzale D, Garrett JW, Condon SE et al. Risk for colon adenomas in patients with rectosigmoid hyperplastic polyps. Ann Intern Med 1990;113:760-3.
63. Bariol C, Hawkins NJ, Turner JJ et al. Histopathological and clinical evaluation of serrated adenomas of the colon and rectum. Mod Pathol 2003;16:417-23.
64. Di Sario JA, Foutch PG, Mai HD et al. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991;86:941-5.
65. Hofmeister M, Schmitz S, Karmrodt E et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol 2010; 8: 870-6.
66. Carr NJ, Mahajan H, Tan KL et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009;62:516-8.
67. Spring KJ, Zhao ZZ, Karamatic R et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-7.
68. Lu FI, van Niekerkde W, Owen D et al. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010;34:927-34.
69. Pai RK, Hart J, Nofsinger AE. Sessile serrated adenomas strongly predis-pose to synchronous serrated polyps in non-syndromic patients. Histopa-thology 2010;56:581-8.
70. Higuchi T, Sugihara K, Jass Jr. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005;47:32-40.
71. Gurudu SR, Heigh RI, De Petris G et al. Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol 2010;16:3402-5.
72. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-6.
73. Hetzel J, Huang CS, Coukos JA et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastro-enterol 2010;105:2656-64.
74. Sanaka M, Gohel T, Podugu A et al. Quality indicators to enhance adenoma detection rate: should there be reconsideration of the current standard? Gastrointest Endosc 2011;73:AB138.
75. Morimoto LM, Newcomb PA, Ulrich CM et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 2002;11 (10 Part 1): 1012-8.
76. Ji BT, Weissfeld JL, Chow WH et al. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006;15:897-901.
77. Paskett ED, Reeves KW, Pineau B et al. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control 2005;16:1021-33.
78. Kearney J, Giovannucci E, Rimm EB et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control 1995;6:45-56.
79. Martinez ME, McPherson RS, Levin B et al. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterol-ogy 1997;113:423-9.
80. Shrubsole MJ, Wu H, Ness RM et al. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 2008;167:1050-8.
81. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010; 139: 1497-502.
82. Wallace K, Grau MV, Ahnen D et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2009;18:2310-7.
83. Anderson JC, Rangasamy P, Rustagi T et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol 2011;45:694-9.
84. Tiis-Evensen E, Hof GS, Sauar J. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999;45:834-9.
85. Lin OS, Gerson LB, Soon MS, Schembre DB et al. Riskofproximal colon neoplasia with distal hyperplastic polyps: a meta-analysis. Arch Intern Med 2005;165:382-90.
86. Li D, Jin C, McCulloch C et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009;104:695-702.
87. Rondagh EJ, Masclee AA, Bouwens MW et al. Endoscopic red flags for the detection of high-risk serrated polyps: an observational study. Endoscopy 2011;43:1052-8.
88. Vu HT, Lopez R, Bennett A et al. Individuals with sessile serrated polyps express an aggressive colorectal phenotype. Dis Colon Rectum 2011; 54: 1216-23.
89. Liljegren A, Lindblom A, Rotstein S et al. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003;52:1140-7.
90. Liljegren A, Barker G, Elliott F et al. Prevalence of adenomas and hyper-plastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. J Clin Oncol 2008;26:3434-9.
91. Rijcken FE, van der Sluis T, Hollema H et al. Hyper plastic polypsin hereditary nonpolyposis colorectal cancer. Am J Gastroenterol 2003;98: 2306-11.
92. Andersen SH, Lykke E, Folker MB et al. Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families. Fam Cancer 2008; 7: 157-62.
93. Bensen SP, Cole BF, Mott LA et al. Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study Lancet 1999;354:1873-4.
94. Laiyemo AO, Murphy G, Sansbury LB et al. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroen-terol Hepatol 2009; 7: 192-7.
95. Imperiale TF, Glowinski EA, Lin-Cooper C et al. Five-year riskofcolorectal neoplasia afer negative screening colonoscopy. N Engl J Med 2008;359: 1218-24.
96. Croizet O, Moreau J, Arany Y et al. Follow-up of patients with hyperplastic polyps of the large bowel. Gastrointest Endosc 1997;46:119-23.
97. Qasim A, Muldoon C, McKiernan S. Colonic adenoma patients have higher incidence of hyperplastic polyps on surveillance colonoscopy. Eur J Gastroenterol Hepatol 2009;21:877-81.
98. Huang EH, Whelan RL, Gleason NR et al. Increased incidence of color-ectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps. Surg Endosc 2001;15:646-8.
99. Lazarus R, Junttila OE, Karttunen TJ et al. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 2005; 123: 349-59.
100. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol 2012; 47: 178-83.
101. Yamauchi T, Watanabe M, Hasegawa H et al. Serrated adenoma developing into advanced colon cancer in 2 years. J Gastroenterol 2002;37:467-70.
102. Oono Y, Fu K, Nakamura H et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54:906-9.
103. Tanaka M, Kusumi T, Sasaki Y et al. Colonic intra-epithelial carcinoma occurring in a hyperplastic polyp via a serrated adenoma. Pathol Int 2001;51:215-20.
104. Garcia-Solano J, Perez-Guillermo M, Conesa-Zamora P et al. Clinico-pathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 2010;41:1359-68.
105. Eide TJ. Prevalence and morphological features of adenomas of the large intestine in individuals with and without colorectal carcinoma. Histopa-thology 1986;10:111-8.
106. Messick CA, Church J, Casey G et al. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps. Dis Colon Rectum 2009; 52: 1535-41.
107. Hiraoka S, Kato J, Fujiki S et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010;139:1503-10.
108. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001; 93: 1307-13.
109. Nosho K, Kure S, Irahara N et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609-20.
110. Church JM. Clinical significance of small colorectal polyps. Dis Colon Rectum 2004; 47: 481-5.
111. Waye JD, Bilotta JJ. Rectal hyperplastic polyps: now you see them, now you don't-a difierential point. Am J Gast roenterol 1990; 85: 1557-9.
112. Tadepalli US, Feihel D, Miller KM et al. A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc 2011;74:1360-8.
113. Rex DK. Update on colonoscopic imaging and projections for the future. Clin Gastroenterol Hepatol 2010; 8: 318-21.
114. Kimura T, Yamamoto E, Yamano HO et al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol 2012;107:460-9.
115. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003;58:76-9.
116. Froehlich F, Wietlisbach V, Gonvers JJ et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005;61:378-84.
117. Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol 2006;12:6161-6.
118. Kahi CJ, Hewett DG, Rex DK. Relationship of non-polypoidco lorectal neoplasms to quality of colonoscopy. Gastrointest Endosc Clin N Am 2010;20:407-15.
119. Kahi CJ, Hewett DG, Norton DL et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011;9:42-6.
120. van Rijn JC, Reitsma JB, Stoker J et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101: 343-50.
121. Rex DK, Bond JH, Winawer S et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308.
122. Rex D, Petrini J, Baron TH et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006;63:S16-28.
123. Chen SC, Rex DK. Variable detection of nonadenomatous polyps by individual endoscopists at colonoscopy and correlation with adenoma detection. J Clin Gastroenterol 2008;42:704-7.
124. Ellis K, Shiel M, Marquis S et al. Effcacy of hot biopsy forceps, cold micro-snare and microsnare with cautery techniques in the removal of diminutive colonic polyps [abstract]. Gastrointest Endosc 1997;45:AB107.
125. Snover D, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Teise ND (eds) WHO Classification of Tumours of the Digestive System. LYON: IARC, 2010, 160-5.
126. Boparai KS, Mathus-Vliegen EM, Koornstra JJ et al. Increased colorec-tal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-100.
127. Carvajal-Carmona LG, Howarth KM, Lockett M et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007;212:378-85.
128. Kalady MF, Jarrar A, Leach B et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011;54:164-70.
129. English DR, Young JP, Simpson JA et al. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 2008; 17: 1774-80.
130. Yeoman A, Young J, Arnold J et al. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J 2007; 120: U2827.
131. Minoo P, Baker K, Goswami R et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55:1467-74.
132. Chow E, Lipton L, Lynch E et al. Hyperplastic polyposis syndrome: phe-notypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30-9.
133. Ferrandez A, Samowitz W, Di Sario JA et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004;99:2012-8.
134. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101-4.
135. Leggett BA, Devereaux B, Biden K et al. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001; 25: 177-84.
136. Rubio CA, Stemme S, Jaramillo E et al. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006; 38: 266-70.
137. Lage P, Cravo M, Sousa R et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastro-enterol 2004;99:1779-84.
138. Rashid A, Houlihan PS, Booker S et al. Phenotypic and molecular charac-teristics of hyperplastic polyposis. Gastroenterology 2000;119:323-32.
139. Boparai KS, Reitsma JB, Lemmens V et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222-5.
140. Winawer SJ, Zauber AG, Fletcher RH et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85.
141. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666-89.
142. Terdiman JP, McQuaid KR. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology 2010;139:1444-7.
143. Aust DE, Baretton GB. Serrated polyps of the colon and rectum (hyper-plastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)-proposal for diagnostic criteria. Virchows Arch 2010;457:291-7.
144. Snover DC. Maximizing the value of the endoscopist-pathologist partnership in the management of colorectal polyps and carcinoma. Gastrointest Endosc Clin N Am 2010;20:641-57.
145. Baxter N, Sutradhar R, Forbes DD et al. Analysis of administrative data finds endoscopist quality measures associated with post-colonoscopy colorectal cancer. Gastroenterology 2011; 140: 65-72.
146. Singh H, Nugent Z, Demers AA et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
147. Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-41.
148. Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroen-terol 2007;102:856-61.
149. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonos-copy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
150. Pabby A, Schoen RE, Weissfeld JL et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the Dietary Polyp Prevention Trial. Gastrointest Endosc 2005;61:385-91.
151. Sawhney MS, Farrar WD, Gudiseva S et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006; 131: 1700-5.
152. Arain MA, Sawhney M, Sheikh S et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010;105:1189-95.
153. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
154. Brenner H, Chang-Claude J, Seiler CM et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22-30.